News blog

Fulcrum Pharma

  • BY: Andrew Hore |
  • POSTED: 12/11/2009 |

Outsourced pharma services provider Fulcrum Pharma reported a swing from profit to loss in the year to August 2009.

Reorganisation costs of 679,000 pushed Fulcrum into loss. Revenues grew from 14.8m to 16.8m thanks to a strong performance in Japan. Currency movements also flattered the figures. The loss of 168,000 compares with a profit of 454,000 in the year to August 2008.

There was net cash of 1.06m at the end of August 2009.

Trading conditions remain difficult but the lower cost base will help.

Shares in Fulcrum declined 0.625p to 2.625p each, which values the company at 4.67m.

© 2022 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds